ChromoGenics AB Cash Flow Statement

CHRO TO2 SEK0.002 0.0 0.0%

29/01/20

Highly Speculative, Micro Cap,

Market Cap £15.0m

Enterprise Value £18.2m

Revenue £1.78m

Quality

Value

Momentum

StockRank™

To unlock ChromoGenics AB's cashflow statement please upgrade your membership.

	2014	2015	2016	2017	2018	2019
Period End:	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31
Period Length:	N/A	12M	12M	12M	12M	12M
Currency:	SEK	SEK	SEK	SEK	SEK	SEK

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Inventories
Accounts Payable
Other Liabilities
Other Operating Cashflow
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Purchase/Acquisition of Intangibles
Other Investing Cash Flow Items, Total
Sale of Fixed Assets
Other Investing Cash Flow
Cash from Investing Activities

Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.